TY - JOUR
T1 - Lymphoma-associated skin cancer
T2 - Incidence, natural history, and clinical management
AU - Brewer, Jerry D.
AU - Habermann, Thomas M.
AU - Shanafelt, Tait D.
PY - 2014/3
Y1 - 2014/3
N2 - The link between immunosuppression and skin cancer has been well described. The two most common situations involving immunosuppression-associated skin cancer are solid organ transplantation and non-Hodgkin lymphoma (NHL), including chronic lymphocytic leukemia (CLL). Patients with lymphoma are more likely to have development of a secondary malignancy, with skin cancer being the most common. The most common types of skin cancer in patients with NHL/CLL include melanoma, squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Many skin cancers demonstrate increased aggressiveness in patients with NHL/CLL and are associated with higher recurrence rates, increased regional metastasis, and death secondary to skin cancer metastases. This review delineates the current research regarding the relationship between NHL/CLL and cutaneous malignancy. Immunosuppressed patients with skin cancer should be treated promptly and aggressively to decrease recurrence and metastases. Regular skin self-examinations, dermatologic examinations, sun-protective habits, and education may prove beneficial in this high-risk patient population.
AB - The link between immunosuppression and skin cancer has been well described. The two most common situations involving immunosuppression-associated skin cancer are solid organ transplantation and non-Hodgkin lymphoma (NHL), including chronic lymphocytic leukemia (CLL). Patients with lymphoma are more likely to have development of a secondary malignancy, with skin cancer being the most common. The most common types of skin cancer in patients with NHL/CLL include melanoma, squamous cell carcinoma, basal cell carcinoma, and Merkel cell carcinoma. Many skin cancers demonstrate increased aggressiveness in patients with NHL/CLL and are associated with higher recurrence rates, increased regional metastasis, and death secondary to skin cancer metastases. This review delineates the current research regarding the relationship between NHL/CLL and cutaneous malignancy. Immunosuppressed patients with skin cancer should be treated promptly and aggressively to decrease recurrence and metastases. Regular skin self-examinations, dermatologic examinations, sun-protective habits, and education may prove beneficial in this high-risk patient population.
UR - http://www.scopus.com/inward/record.url?scp=84894279773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894279773&partnerID=8YFLogxK
U2 - 10.1111/ijd.12208
DO - 10.1111/ijd.12208
M3 - Review article
C2 - 24320558
AN - SCOPUS:84894279773
SN - 0011-9059
VL - 53
SP - 267
EP - 274
JO - International journal of dermatology
JF - International journal of dermatology
IS - 3
ER -